Lv1
92 积分 2022-10-28 加入
Progress and challenges in developing allogeneic cell therapies
9天前
已关闭
Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies
23天前
已完结
The pathogenesis of Parkinson's disease
23天前
已完结
CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy
29天前
已完结
Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma
1个月前
已完结
Barriers to CAR T-cell therapy in rheumatology
1个月前
已完结
PD-1-CD28-enhanced receptor and CD19 CAR-modified tumor-infiltrating T lymphocytes produce potential anti-tumor ability in solid tumors
3个月前
已完结
Peripheral blood–derived PD-1/CD28–CD19-CAR–modified PD-1+ T-cell therapy in patients with solid tumors
3个月前
已完结
TREM1/DAP12 based novel multiple chain CAR‐T cells targeting DLL3 show robust anti‐tumour efficacy for small cell lung cancer
3个月前
已完结
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
3个月前
已完结
皖公网安备34019202002308
